Generic placeholder image

Letters in Organic Chemistry

Editor-in-Chief

ISSN (Print): 1570-1786
ISSN (Online): 1875-6255

Research Article

Synthesis of N-substituted-2-amino-3,4,5-trimethoxybenzoylindoles as Novel Anticancer Agents

Author(s): Vijay K. Patel and Harish Rajak*

Volume 15 , Issue 11 , 2018

Page: [931 - 939] Pages: 9

DOI: 10.2174/1570178615666180212161459

Price: $65

Abstract

A series of novel N-substituted-2-amino-3,4,5-trimethoxybenzoylindoles was synthesized and assessed against human cancer cell lines of breast (MCF-7) and colon (HT-29). The two derivatives 7a and 11a, in which the hydrogen atom at position 1 was substituted by a methyl and a benzoyl group respectively, showed significant cytotoxic activity GI50 against MCF-7 (0.045 µM), HT-29 (4.25 µM) and MCF-7 (0.035 µM) HT-29 (0.856 µM). Molecular docking studies indicated that compounds 7a and 11a possess hydrogen bond interaction between SH group of Cys 241 of receptor molecule and para position of trimethoxyphenyl group of benzoyl moiety, while compound 11a has an extra hydrogen bond interaction between Ser 178 of receptor molecule and keto group of benzoyl moiety. The compound 11a showed high solvent-exposed penalty due to the presence of phenyl ring of benzoyl molecule, thus compound 11a showed low Gscore and lesser potent as compared to 7a.

Keywords: Anticancer, combretastatin A-4, docking, N-substituted-2-amino-3, 4, 5-trimethoxybenzoylindole, synthesis, MCF-7.

Graphical Abstract

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy